View Item 

Show simple item record

Pharmacokinetics of Torsemide in Patients with Decompensated and Compensated Congestive Heart Failure
dc.contributor.authorBleske, Barry E.en_US
dc.contributor.authorWelage, Lynda S.en_US
dc.contributor.authorKramer, William G.en_US
dc.contributor.authorNicklas, John M.en_US
dc.date.accessioned2013-04-08T20:49:32Z
dc.date.available2013-04-08T20:49:32Z
dc.date.issued1998-08en_US
dc.identifier.citationBleske, Barry E.; Welage, Lynda S.; Kramer, William G.; Nicklas, John M. (1998). "Pharmacokinetics of Torsemide in Patients with Decompensated and Compensated Congestive Heart Failure." The Journal of Clinical Pharmacology 38(8). <http://hdl.handle.net/2027.42/97165>en_US
dc.identifier.issn0091-2700en_US
dc.identifier.issn1552-4604en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/97165
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titlePharmacokinetics of Torsemide in Patients with Decompensated and Compensated Congestive Heart Failureen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumCollege of Pharmacy, University of Michigan, and the University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherClinical Research, Boehringer Mannheim Corporation, Gaithersburg, Marylanden_US
dc.identifier.pmid9725546en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/97165/1/j.1552-4604.1998.tb04810.x.pdf
dc.identifier.doi10.1002/j.1552-4604.1998.tb04810.xen_US
dc.identifier.sourceThe Journal of Clinical Pharmacologyen_US
dc.identifier.citedreferenceSchwartz S, Brater DC, Pound D, Green PK, Kramer WG, Rudy D: Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis. Clin Pharmacol Ther 1993; 54: 90 – 97.en_US
dc.identifier.citedreferenceGehr TWB, Rudy DW, Matzke GR, Kramer WG, Sica DA, Brater DC: The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency. Clin Pharmacol Ther 1994; 56: 31 – 38.en_US
dc.identifier.citedreferenceVasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC: Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 1985; 102: 314 – 318.en_US
dc.identifier.citedreferenceLi T, Lee MG, Chiou WL: Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide. J Pharmacokinet Biopharm 1986; 14: 495 – 509.en_US
dc.identifier.citedreferenceHammarlund MM, Odlind B, Paalzow KW: Acute tolerance to furosemide diuresis in humans: pharmacokinetic‐pharmacodynamic modeling. J Pharmacol Exp Ther 1985; 233: 447 – 453.en_US
dc.identifier.citedreferenceCavalier R, Pellegrin P, Lesne J, van de Strihou Ypersele CH: Site of action of torsemide in man. Eur J Clin Pharmacol 1986; 31 ( Suppl ): 15 – 19.en_US
dc.identifier.citedreferenceMarch C, Farthing D, Wells B, Besenfelder E, Karnes HT: Solid phase extraction and liquid chromatography of torsemide and metabolites from plasma and urine. J Pharm Sci 1990; 79: 453 – 457.en_US
dc.identifier.citedreferenceVargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC: Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with congestive heart failure. Clin Pharmacol Ther 1995; 57: 601 – 609.en_US
dc.identifier.citedreferenceWilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW, Friedman PA, Souney PF: Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 1983; 102: 450 – 458.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1552-4604.1998.tb04810.x.pdf
Size:
1.050MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.